Please check your internet connection and try again.
# Hyoscine butylbromide
## Overview
Hyoscine butylbromide is an anticholinergic medication that acts as a smooth muscle antispasmodic. It competitively inhibits muscarinic acetylcholine receptors, primarily in the smooth muscle of the gastrointestinal and genitourinary tracts.
## Primary Indications
* Symptomatic relief of abdominal pain and cramping associated with irritable bowel syndrome (IBS).
* Relief of spasms in the urinary tract.
* Short-term treatment for acute intestinal colic.
## Adult Dosing
* **Oral:** 10 mg to 20 mg three to five times daily. Maximum daily dose not explicitly established, but generally advised to be kept reasonable (e.g., not exceeding 80 mg daily).
* **Injection (Intramuscular/Subcutaneous/Intravenous):** 20 mg every 4-6 hours as needed. Maximum daily dose generally 100 mg. For acute colic, up to 40 mg may be given. Dosing for IV administration should be slow to minimize cardiovascular effects.
## Pediatric Dosing
* **Oral:** Dosing is less well-established in pediatrics. Some sources suggest 5 mg to 10 mg two to three times daily for children 6 to 12 years of age. Below 6 years, use is generally not recommended or requires very careful consideration and physician guidance due to limited safety data and potential for adverse effects.
* **Injection:** Not generally recommended for routine pediatric use due to increased risk of adverse effects. Use should be guided by specialist opinion and limited to specific indications where benefits outweigh risks.
## Dose Adjustments
No specific dose adjustments are routinely required for hepatic or renal impairment, as the drug is poorly absorbed systemically and has minimal hepatic metabolism. However, caution is advised in elderly patients due to increased susceptibility to anticholinergic side effects.
## Contraindications
* Hypersensitivity to hyoscine butylbromide or any component of the formulation.
* Myasthenia gravis.
* Narrow-angle glaucoma.
* Tachyarrhythmias.
* Mechanical obstruction of the gastrointestinal tract or urinary tract.
* Ileus or paralytic ileus.
* Atropine poisoning.
* Cystic fibrosis (especially with higher doses).
* Prostatic hypertrophy with urinary retention.
## Adverse Effects
Common adverse effects are typically anticholinergic:
* Dry mouth
* Blurred vision
* Tachycardia
* Urinary retention
* Constipation
* Drowsiness
* Dizziness
Less common:
* Skin rash
* Anhidrosis (decreased sweating)
* Mydriasis (pupil dilation)
Serious:
* Angle-closure glaucoma
* Severe allergic reactions
## Key Drug Interactions
* **Anticholinergic agents (e.g., tricyclic antidepressants, antihistamines, antipsychotics):** Additive anticholinergic effects increase risk of dry mouth, constipation, urinary retention, and blurred vision.
* **Prokinetic agents (e.g., metoclopramide):** Hyoscine butylbromide may antagonize the effects of prokinetic agents.
* **Beta-agonists:** May increase heart rate.
## Monitoring
* Monitor for relief of symptoms.
* Monitor for anticholinergic side effects (dry mouth, blurred vision, urinary retention, constipation, tachycardia).
* Assess patients with pre-existing conditions (e.g., glaucoma, prostatic hypertrophy) for worsening symptoms.
## Clinical Pearls
* Hyoscine butylbromide has a quaternary ammonium structure, which limits its penetration into the central nervous system, thus having fewer CNS side effects compared to centrally acting anticholinergics like atropine.
* Intravenous administration can provide rapid relief for acute colic but carries a higher risk of adverse effects, particularly tachycardia.
* Ensure adequate hydration, especially if constipation is a side effect.
* Use with caution in hot weather due to potential for decreased sweating (anhidrosis) and risk of heat stroke.
***
*Disclaimer: This information is intended for clinical use and does not replace professional medical judgment. Always verify current prescribing information and consult relevant guidelines before initiating, modifying, or discontinuing any medication.*
